Clinical trial

Metabolic Surgery for Atrial Fibrillation Elimination

NCT07027969

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-11-01

PhasePHASE4

Study timeline

Study start (estimated)2026-11-01Date precision: day

Registry last updated2026-04-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Atrial Fibrillationverified · MONDO: atrial fibrillation

Obesity and Obesity-related Medical Conditionsunresolved

Interventions

Roux-en-Y Gastric Bypass or Sleeve GastrectomyPROCEDURE

Anti-Obesity Medication (AOM) treatmentDRUG

Sponsors & collaborators

Ali Aminianlead sponsor

Ethicon, Inc.collaborator

iRhythm Technologies, Inc.collaborator

Mapped research locations

ClevelandOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07027969 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.